The beauty is we're going to have plenty of time to watch all their next calculated moves unfold...and I'm beyond convinced from what we've all already been witnessing here over these past few years...that they'll be making the smartest/best growth driving decisions possible...especially when it comes to their revolutionary tamper proof Rexista!
Just listening to the CEO's enthusiasm the other day on that BNN television interview when talking about Rexista you could tell that whatever he's got planned for it it's going to be phenomenal;)
Sorry. I may have misread your post. If you meant manufacturing of Rexista in-house, then that makes a lot of sense, and debt financing would be the right path.
But, I still think we need a large pharma marketing partner.